ArticleAdvances in radiation oncology

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.

Stephen R Bowen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.